Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

NCT03706430 is registered in ClinicalTrials.gov with Masimo Corporation as lead sponsor.

NCT NCT03706430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03706430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of RPVi as a Parameter to Predict Fluid Responsiveness
Lead sponsor
Masimo Corporation
Phase
Not reported
Overall status
Terminated
Start date
September 24, 2018
Completion date
October 20, 2021
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, surgery